Cargando…

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands

INTRODUCTION: There is little information as to what extent adverse drug reactions (ADRs) influence patients’ health-related quality of life (HR-QOL). From a pharmacovigilance perspective, capturing and making the best use of this information remains a challenge. The Netherlands Pharmacovigilance Ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rolfes, Leàn, van Hunsel, Florence, Taxis, Katja, van Puijenbroek, Eugène
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933735/ https://www.ncbi.nlm.nih.gov/pubmed/27145946 http://dx.doi.org/10.1007/s40264-016-0422-0

Ejemplares similares

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
por: Rolfes, Leàn, et al.
Publicado: (2017)

Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database
por: Rolfes, Leàn, et al.
Publicado: (2018)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
por: Scholl, Joep H.G., et al.
Publicado: (2017)

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands
por: van der Boor, Saskia C., et al.
Publicado: (2023)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

Time to onset in statistical signal detection revisited: A follow‐up study in long‐term onset adverse drug reactions
por: Scholl, Joep H.G., et al.
Publicado: (2019)

Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approach
por: Sabblah, George Tsey, et al.
Publicado: (2022)

COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes
por: Rolfes, Leàn, et al.
Publicado: (2022)

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands
por: Dittrich, Anne T. M., et al.
Publicado: (2020)

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product
por: van Hunsel, Florence, et al.
Publicado: (2015)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
por: Ekhart, Corine, et al.
Publicado: (2022)

Adverse drug reactions of montelukast in children and adults
por: Haarman, Meindina G., et al.
Publicado: (2017)

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience
por: Oosterhuis, Ingrid, et al.
Publicado: (2022)

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care
por: Denig, Petra, et al.
Publicado: (2019)

Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana
por: Sabblah, George Tsey, et al.
Publicado: (2019)

Severe Secondary Polycythemia in a Female-to-Male Transgender Patient While Using Lifelong Hormonal Therapy: A Patient’s Perspective
por: Ederveen, Ellen G. T., et al.
Publicado: (2018)

Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
por: Zulzaga, Zuzaan, et al.
Publicado: (2021)

The experienced positive and negative influence of HIV on quality of life of people with HIV and vulnerable to HIV in the Netherlands
por: Romijnders, Kim A. G. J., et al.
Publicado: (2022)

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions
por: Reumerman, M., et al.
Publicado: (2021)

The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study
por: Schutte, Tim, et al.
Publicado: (2017)

Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb
por: Vrolijk, Misha F., et al.
Publicado: (2020)

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study
por: de Vries, Sieta T., et al.
Publicado: (2020)

The quality of maternity care services as experienced by women in the Netherlands
por: Wiegers, Therese A
Publicado: (2009)

Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Kant, Agnes, et al.
Publicado: (2022)

Electronic Health Record–Triggered Research Infrastructure Combining Real-world Electronic Health Record Data and Patient-Reported Outcomes to Detect Benefits, Risks, and Impact of Medication: Development Study
por: Hek, Karin, et al.
Publicado: (2022)

Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient’s Perspective
por: van Lint, Jette A., et al.
Publicado: (2023)

Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors
por: Bots, Sophie H., et al.
Publicado: (2022)

Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands
por: Kant, Agnes, et al.
Publicado: (2022)

Pediatrician-experienced barriers in the medical care for refugee children in the Netherlands
por: Baauw, A., et al.
Publicado: (2018)

Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study
por: Schutte, Tim, et al.
Publicado: (2017)

Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
por: Dittrich, Anne T. M., et al.
Publicado: (2022)

What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects
por: van Eekeren, Rike, et al.
Publicado: (2018)

Anaphylactic Reaction to Tc-99m Macrosalb
por: Schreuder, Nanno, et al.
Publicado: (2019)

Quality of life of adult retinoblastoma survivors in the Netherlands
por: van Dijk, Jennifer, et al.
Publicado: (2007)

Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward
por: Noorda, Nikki M. F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rgo98ti63e4n2ak0d32gcho7cl